Introduction
The therapeutic landscape for Alzheimer's treatments is presently facing significant attention. Recently, the UK’s National Institute for Health and Care Excellence (NICE) evaluated lecanemab, a drug aimed at slowing cogniti...
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.